LIGAND PHARMACEUTICALS INC (LGND) Operating cash flow 2016–2025
LIGAND PHARMACEUTICALS INC (LGND) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$49.4MFY2025 · since FY2016: $60.7M → $49.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $49.4M | -49.1% |
| FY2024 | $97.0M | +95.8% |
| FY2023 | $49.6M | -64.0% |
| FY2022 | $137.8M | +74.9% |
| FY2021 | $78.8M | +44.4% |
| FY2020 | $54.6M | +286.1% |
| FY2019 | -$29.3M | -115.1% |
| FY2018 | $194.1M | +119.1% |
| FY2017 | $88.6M | +45.8% |
| FY2016 | $60.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice